Is Cystic Fibrosis Carrier Screening Cost Effective?

By  

Public Health Genomics, Vol. 10, Iss. 2, 2007-03 ,pp. : 103-109

Karger

Access to resources Recommend Favorite

How Should Preconceptional Cystic Fibrosis Carrier Screening Be Provided? Opinions of Potential Providers and the Target Population

By  

Public Health Genomics, Vol. 6, Iss. 3, 2004-06 ,pp. : 157-165

Karger

Access to resources Recommend Favorite

Adenoviral gene therapy of the Tay-Sachs disease in hexosaminidase A-deficient knock-out mice

By Guidotti J.E.   Mignon A.   Haase G.   Caillaud C.   McDonell N.   Kahn A.   Poenaru L.  

Human Molecular Genetics, Vol. 8, Iss. 5, 1999-05 ,pp. : 831-838

Oxford University Press

Access to resources Recommend Favorite

A direct gene transfer strategy via brain internal capsule reverses the biochemical defect in Tay–Sachs disease

By Martino S.  

Human Molecular Genetics, Vol. 14, Iss. 15, 2005-08 ,pp. : 2113-2123

Oxford University Press

Access to resources Recommend Favorite

Origin and spread of the 1278insTATC mutation causing Tay-Sachs disease in Ashkenazi Jews: genetic drift as a robust and parsimonious hypothesis

By Frisch Amos   Colombo Roberto   Michaelovsky Elena   Karpati Mazal   Goldman Boleslaw   Peleg Leah  

Human Genetics, Vol. 114, Iss. 4, 2004-03 ,pp. : 366-376

Springer Publishing Company

Access to resources Recommend Favorite